Startup, Biotech, Entrepreneurship, Startup Funding, Fundraising For Startups.
nucleoside analogue that will be able to kill the bacteria. This is how Theralia is planning to cure infections in the future in humans. Their technology, TOUCAN, consists of several advantages such as personalized treatment of severe localized infections, enhanced safety profile and efficacy of